OBI Pharma 's 2016 Annual General Meeting has approved to release the newly elected Director from non-competition restriction

1.Date of the shareholders’ meeting resolution:2016/06/27 2.Name and title of the director with permission to engage in competitive conduct: Director  Michael Chang (Representative of Yi Tai Fund Co.) Director  Tamon Tseng (Representative of Yi Tai Fund Co.) Director  Lung-Yeh Cho (Representative of Sun Cheng Fund Co.) Director  Frank Chen (Representative of Sun Cheng Fund Co.) […]